Prospector Partners LLC Merck & Co., Inc. Transaction History

Prospector Partners LLC

$915 Million
Q3 2024

A detailed history of Prospector Partners LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Prospector Partners LLC holds 162,848 shares of MRK stock, worth $16.2 Million. This represents 2.02% of its overall portfolio holdings.

Number of Shares

162,848

Previous 162,111 0.45%

Holding current value

$16.2 Million

Previous $20.1 Million 7.85%

% of portfolio

2.02%

Previous 2.33%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$111.15 - $128.97 $81,917 - $95,050	737 Added 0.45%	162,848 $18.5 Million
Q2 2024 Aug 13, 2024	BUY	$123.8 - $132.96 $131,723 - $141,469	1,064 Added 0.66%	162,111 $20.1 Million
Q1 2024 May 09, 2024	BUY	$113.24 - $131.95 $323,866 - $377,376	2,860 Added 1.81%	161,047 $21.3 Million
Q4 2023 Feb 09, 2024	BUY	$100.18 - $109.02 $61,109 - $66,502	610 Added 0.39%	158,187 $17.2 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $53,019 - $58,879	515 Added 0.33%	157,577 $16.2 Million
Q2 2023 Aug 10, 2023	SELL	$108.61 - $118.38 $312,253 - $340,342	-2,875 Reduced 1.8%	157,062 $18.1 Million
Q1 2023 May 08, 2023	SELL	$102.94 - $114.86 $1.79 Million - $1.99 Million	-17,365 Reduced 9.79%	159,937 $17 Million
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $1.53 Million - $1.96 Million	-17,486 Reduced 8.98%	177,302 $19.7 Million
Q3 2022 Nov 10, 2022	SELL	$84.53 - $94.96 $458,152 - $514,683	-5,420 Reduced 2.71%	194,788 $16.8 Million
Q2 2022 Aug 11, 2022	SELL	$83.49 - $94.64 $834,900 - $946,400	-10,000 Reduced 4.76%	200,208 $18.3 Million
Q1 2022 May 12, 2022	SELL	$73.51 - $82.4 $992,385 - $1.11 Million	-13,500 Reduced 6.03%	210,208 $17.2 Million
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $245,752 - $307,836	-3,400 Reduced 1.5%	223,708 $17.1 Million
Q3 2021 Nov 10, 2021	BUY	$71.68 - $78.83 $111,820 - $122,974	1,560 Added 0.69%	227,108 $17.1 Million
Q2 2021 Aug 11, 2021	SELL	$70.31 - $77.77 $298,817 - $330,522	-4,250 Reduced 1.85%	225,548 $17.5 Million
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $602,525 - $709,712	8,750 Added 3.96%	229,798 $17.7 Million
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $4.25 Million - $4.72 Million	59,250 Added 36.62%	221,048 $18.1 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $457,375 - $518,437	6,250 Added 4.02%	161,798 $13.4 Million
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $781,662 - $889,443	-11,100 Reduced 6.66%	155,548 $12 Million
Q1 2020 May 13, 2020	BUY	$63.36 - $87.82 $1.06 Million - $1.47 Million	16,700 Added 11.14%	166,648 $12.8 Million
Q4 2019 Feb 13, 2020	BUY	$77.58 - $87.54 $93,096 - $105,048	1,200 Added 0.81%	149,948 $13.6 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $1.66 Million - $1.81 Million	-21,800 Reduced 12.78%	148,748 $12.5 Million
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $27,936 - $32,636	400 Added 0.24%	170,548 $14.3 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $1.23 Million - $1.4 Million	-17,700 Reduced 9.42%	170,148 $14.2 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $32,619 - $37,855	500 Added 0.27%	187,848 $14.4 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $138,456 - $162,816	2,400 Added 1.3%	187,348 $13.3 Million
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $757,367 - $889,828	14,900 Added 8.76%	184,948 $11.2 Million
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $142,688 - $165,844	-2,800 Reduced 1.62%	170,048 $9.26 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $583,306 - $696,532	11,300 Added 6.99%	172,848 $9.73 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $1.22 Million - $1.31 Million	20,800 Added 14.78%	161,548 $10.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	140,748	140,748 $9.02 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospector Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prospector Partners LLC with notifications on news.

Account

Prospector Partners LLC Merck & Co., Inc. Transaction History